Cornelius Miething

18PUBLICATIONS
150CO-AUTHORS
Tumour immunologyHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 28, 2026
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

|Mar 06, 2026
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

Laura Polcik, Abhishek Pethe, Driti Ashok

|Jul 12, 2025
Modeling the t(2;5) Translocation of Anaplastic Large Cell Lymphoma Using CRISPR-Mediated Chromosomal Engineering.

Robin Khan, Laurent Phely, Sophia Ehrenfeld

|Jan 10, 2024
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease.

Kristina Maas-Bauer, Anna-Verena Stell, Kai-Li Yan

|Jan 25, 2023
Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.

Amelie Jaeger, Sudheer Madan Mohan Gambheer, Xiaoyang Sun

|Jul 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.

Jenny N H G Ho, Dominik Schmidt, Theresa Lowinus

Pageof 3

Frequent Collaborators

6 joint publications

Melanie Boerries

6 joint publications

Geoffroy Andrieux

5 joint publications

Robert Zeiser

5 joint publications

Justus Duyster